If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 548.20
Bid: 546.40
Ask: 546.60
Change: 13.20 (2.47%)
Spread: 0.20 (0.037%)
Open: 536.60
High: 548.20
Low: 536.20
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

20 Jun 2023 10:01

RNS Number : 2970D
B&M European Value Retail S.A.
20 June 2023
 

 

20 June 2023

B&M European Value Retail S.A.

Board Appointment

 

B&M European Value Retail S.A. (the "Company") announces the following Board changes.

 

Hounaïda Lasry is to be appointed, subject to shareholder approval, as a Non-Executive Director of the Company with effect from 22 September 2023 when she will also join the Remuneration and Nomination Committees.

 

Hounaïda is currently a Non-Executive Director at Britvic plc.

 

Hounaïda had almost 30 years' experience at Procter & Gamble across various sectors (Skin & Personal Care, Pet Food, Sanitary Pads, Diapers and Detergents) and geographies (Europe, Middle East, Africa and Asia). In her final role, she had responsibility for a portfolio of 5 brands across Europe, backed by strong operational experience in leading business turnarounds and organization transformation.

 

From 2016 to 2021, Hounaïda was a Non-Executive Director on the Advisory Board of the Geneva School of Economics and Management.

 

 

Peter Bamford, Chairman, said

 "I am delighted that Hounaïda has agreed to join the Board of B&M. She brings strong commercial international, and strategic instincts and the benefits of experience gained in a wide variety of challenging operational roles within the highly structured and developed consumer facing disciplines of Procter and Gamble. Hounaïda will enhance the diversity of experience and skills on our Board considerably"

 

 

With regard to Hounaïda Lasry's appointment to the Board on 22 September 2023, as there is currently no vacancy in the office of a Director of the Company, in accordance with Luxembourg law, her appointment is required to be approved by a resolution of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders is to be convened during September 2023 (the "Meeting") for that purpose. Subject to her appointment being approved at the Meeting, it will take effect on 22 September 2023. Further announcements will be made to confirm when the notice of the Meeting has been despatched to shareholders, and also following the Meeting to confirm the outcome of the resolution to approve the appointment.

 

The Company makes this announcement in accordance with LR 9.6.11R of the Listing Rules. There are no other matters to be disclosed under LR9.6.13R in relation to the appointment of Hounaïda Lasry.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Alex Russo, Chief Executive Officer

Mike Schmidt, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Sam Cartwright

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPKEASXDEEA
Date   Source Headline
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report
2nd Nov 202212:06 pmRNSConfirmation of timing of Interim Results
31st Oct 20229:23 amRNSAppointment of directors- Result of Meeting
18th Oct 20223:51 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSNotice of GM
15th Sep 20228:20 amRNSManagement Succession and Board Update
9th Sep 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20223:06 pmRNSDirector/PDMR Shareholding
31st Aug 20223:01 pmRNSTotal Voting Rights
18th Aug 20227:00 amRNSBoard Appointment and Retirement
5th Aug 20224:41 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSAppointment of Joint Corporate Broker
3rd Aug 202212:12 pmRNSTR1 Notification
29th Jul 202210:28 amRNSAGM Voting Results
14th Jul 202212:07 pmRNSBlock Listing Application
13th Jul 20223:48 pmRNSBlock listing Interim Review
5th Jul 20227:00 amRNSBoard appointment
29th Jun 20227:00 amRNSQ1 FY23 Trading Update
21st Jun 20227:00 amRNSAnnual Financial Report and Notice of AGM
16th Jun 20229:55 amRNSHolding(s) in Company
9th Jun 20221:17 pmRNSHolding(s) in Company
9th Jun 202212:16 pmRNSDirector/PDMR grant of options
8th Jun 20227:00 amRNSDirector/PDMR Notice
31st May 20227:01 amRNSFY22 Preliminary Results
31st May 20227:00 amRNSCEO Succession
22nd Apr 20227:00 amRNSCEO Succession Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.